Kedar Purushottam Phadke
Keine laufenden Positionen mehr
Karriereverlauf von Kedar Purushottam Phadke
Ehemalige bekannte Positionen von Kedar Purushottam Phadke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| THERMAX LIMITED | Compliance Officer | 08.08.2017 | 19.08.2021 |
| Investor Relations Kontakt | 08.08.2017 | 19.08.2021 | |
| Unternehmenssekretär | 08.08.2017 | 19.08.2021 | |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Unternehmenssekretär | 19.11.2010 | - |
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | General Counsel | 01.12.2009 | - |
| Unternehmenssekretär | 01.12.2009 | - |
Statistik
International
| Indien | 4 |
Operativ
| Corporate Secretary | 3 |
| General Counsel | 1 |
| Compliance Officer | 1 |
Sektoral
| Producer Manufacturing | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
| THERMAX LIMITED | Producer Manufacturing |
| Private Unternehmen | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |